ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $768,000 | +32.0% | 208,587 | +1.5% | 0.00% | 0.0% |
Q2 2018 | $582,000 | -22.8% | 205,487 | +1.1% | 0.00% | 0.0% |
Q1 2018 | $754,000 | +20.6% | 203,287 | +163.3% | 0.00% | 0.0% |
Q3 2016 | $625,000 | -44.6% | 77,208 | -46.6% | 0.00% | -50.0% |
Q2 2016 | $1,128,000 | +2.1% | 144,608 | +1.1% | 0.00% | 0.0% |
Q1 2016 | $1,105,000 | -17.8% | 143,100 | +14.8% | 0.00% | -33.3% |
Q4 2015 | $1,344,000 | +53.6% | 124,600 | -1.7% | 0.00% | +50.0% |
Q3 2015 | $875,000 | +135.8% | 126,700 | +179.1% | 0.00% | +100.0% |
Q2 2013 | $371,000 | – | 45,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |